Clinical Data Management Systems (CDMS) Market Report 2026

The clinical data management systems (cdms) market size has grown rapidly in recent years. It will grow from $3.27 billion in 2025 to $3.7 billion in 2026 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to growth in global clinical trial volumes, transition from paper-based data collection, increasing regulatory scrutiny on trial data, expansion of multinational clinical studies, rising demand for centralized data oversight.

The clinical data management systems (cdms) market size is expected to see rapid growth in the next few years. It will grow to $6.04 billion in 2030 at a compound annual growth rate (CAGR) of 13%. The growth in the forecast period can be attributed to increasing adoption of decentralized clinical trials, rising demand for real-time trial analytics, expansion of ai-enabled data monitoring tools, growing focus on data integrity and security, increased outsourcing to contract research organizations. Major trends in the forecast period include increasing adoption of cloud-based cdms platforms, rising integration with clinical trial management systems, growing use of real-time data validation tools, expansion of remote trial data management, enhanced focus on regulatory-compliant data handling.

The growing volume and increasing complexity of clinical trials are expected to drive the growth of the clinical data management systems (CDMS) market in the coming years. Clinical trials are research studies conducted to evaluate medical, surgical, or behavioral interventions. Clinical data management systems play a critical role in clinical trials by ensuring accurate data collection, integration, and availability for analysis, which improves the reliability and speed of research outcomes. For instance, in February 2024, according to ClinicalTrials.gov, a US-based government web resource, 4,024 clinical trials reported results in 2022, and this number increased to 5,063 in 2023. Therefore, the rising volume and complexity of clinical trials are contributing to the growth of the clinical data management systems market.

Major companies operating in the clinical data management systems market are focusing on the development of advanced technologies such as health intelligence platforms to strengthen their market position. A health intelligence platform is an integrated technological solution that uses data analytics and artificial intelligence to improve efficiency, accuracy, and insights derived from clinical trial data management. For example, in April 2023, Orion Health Group Limited, a New Zealand-based healthcare software company, launched Orchestral. Orchestral transforms healthcare data management by offering a flexible platform that supports both cloud-based and on-premise deployments, while incorporating advanced capabilities such as machine learning, natural language processing, and seamless data integration. This development represents a significant step forward in health data analytics, enabling improved decision-making through enhanced efficiency and adaptability.

In June 2025, MRO, a US-based provider of clinical data exchange and disclosure management solutions, acquired Q-Centrix for an undisclosed amount. This acquisition is intended to strengthen MRO’s enterprise clinical data management capabilities, enhance support for health systems through technology-enabled, high-quality data abstraction, and accelerate the development of scalable solutions that improve clinical data integrity and operational efficiency. Q-Centrix is a US-based enterprise clinical data management platform specializing in clinical data abstraction, quality reporting, and regulatory compliance support for healthcare organizations.

Major companies operating in the clinical data management systems (cdms) market are Oracle Corporation, IQVIA Inc., Dassault Systèmes SE, PAREXEL International Corporation, Epic Systems Corporation, Veeva Systems Inc., Medical Information Technology Inc., Clario, Merative L.P., Medrio Inc., Forte Research Systems Inc., Ennov Group, Axiom Real-Time Metrics Inc., MedNet Solutions, eClinical Solutions LLC, Deep 6 AI, Applied Clinical Intelligence LLC, ClinCapture LLC, OpenClinica LLC, Datatrak International Inc., CIMS Global LLC, Novaseek Research Inc., Ofni Systems, OmniComm Systems Inc., EvidentIQ.

North America was the largest region in the clinical data management systems market in 2025. The regions covered in the clinical data management systems (cdms) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical data management systems (cdms) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the clinical data management systems market by increasing costs of imported IT infrastructure, data servers, cybersecurity hardware, and specialized software components supporting CDMS deployments. Pharmaceutical and biotechnology companies in North America and Europe are most affected due to dependence on cross-border software services and infrastructure, while Asia-Pacific faces cost pressures on cloud hosting and system integration. These tariffs are increasing implementation costs and delaying platform upgrades. However, they are also encouraging regional data centers, localized software development, and increased adoption of cloud-native CDMS solutions that reduce reliance on imported hardware.

The clinical data management systems (cdms) market research report is one of a series of new reports that provides clinical data management systems (cdms) market statistics, including clinical data management systems (cdms) industry global market size, regional shares, competitors with a clinical data management systems (cdms) market share, detailed clinical data management systems (cdms) market segments, market trends and opportunities, and any further data you may need to thrive in the clinical data management systems (cdms) industry. This clinical data management systems (cdms) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Clinical data management systems (CDMS) are specialized software solutions used to manage and process data generated during clinical trials, ensuring data accuracy, completeness, and consistency. These systems play a critical role in maintaining data integrity, supporting regulatory compliance, and enabling efficient data analysis and reporting throughout the clinical trial process.

The primary types of clinical data management systems include paper-based systems, electronic data capture systems, and hybrid systems. Paper-based systems involve the use of physical documents to collect and record clinical trial data on case report forms. Key components of CDMS include software and related services, which can be deployed through on-premise or cloud-based models. These systems are used by various end users such as contract research organizations, medical device manufacturers, pharmaceutical and biotechnology companies, and others.

The clinical data management systems market consists of revenues earned by entities by providing services such as data collection, data validation, database design, query management, statistical analysis, and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical data management systems market also includes sales of electronic data capture (EDC) systems, eCRF designers, clinical trial management systems, and reporting and analytics tools that are used in providing services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.